在痴呆症患者中治疗非痴呆症疾病
D J Brauner1, J C Muir, G A Sachs
1The University of Chicago Hospitals, Department of Medicine, 5841 S Maryland, MC 6098, Chicago, IL 60637, USA. dbrauner@medicine.bsd.uchicago.edu
JAMA
|June 24, 2000
概括
照顾阿尔茨海默氏症类型痴呆症患者需要仔细考虑非痴呆症疾病治疗方法. 痴呆症显著改变了治疗风险益处比率,需要调整决策,以获得最佳的患者护理.
科学领域:
- 老年病的医生 老年病的医生
- 神经学 神经学
- 内部医学 内部医学
背景情况:
- 医生为日益增长的阿尔茨海默氏症类型痴呆症人口提供初级保健.
- 痴呆症患者的非痴呆症疾病护理受到有限的关注.
- 痴呆症改变了常见医疗治疗的风险效益比.
研究的目的:
- 举例说明痴呆症如何影响常见疾病的治疗决策.
- 强调在痴呆症患者中管理非痴呆症的挑战.
- 为优化护理和决策提供指导.
主要方法:
- 一个痴呆症患者的病例研究,药物产生不良影响.
- 类似临床情景的复合图片.
- 讨论痴呆症护理中的决策因素.
主要成果:
- 痴呆症的存在需要修改治疗的风险-益处评估.
- 痴呆症患者的副作用可能很严重.
- 认知衰退影响治疗坚持和不良事件报告.
结论:
- 痴呆症对同时存在的疾病的治疗选择产生重大影响.
- 改善沟通和查对于痴呆症患者的护理至关重要.
- 需要改变政策,以便将痴呆症患者纳入临床试验.
相关概念视频
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Treatment Strategies for Psychological Disorders
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


